10 Best Forestry Stocks To Invest In Right Now

Commercial banks in the United States are required to prove to their regulators that their investments are in fact "investment grade" as defined by the regulators. In this note we analyze the current levels and past history of default probabilities for Goldman Sachs Group (GS). We compare those default probabilities to credit spreads on 1,162 bond trades in 134 different company bond issues on July 31, 2013. This trading volume made Goldman Sachs Group the second most heavily traded name on the day, trailing only General Electric (GE) Credit Corporation. Goldman Sachs Group has some of the lowest default probabilities of any firm analyzed in this series of credit notes to date. Trading volume in these 134 Goldman Sachs Group bonds on July 31 totaled $358.3 million, and the analysis in this note is based on those traded prices.

Assuming the recovery rate in the event of default would be the same on all bond issues, a sophisticated investor who has moved beyond legacy ratings seeks to maximize revenue per basis point of default risk from each incremental investment, subject to risk limits on macro-factor exposure on a fully default-adjusted basis. We analyze the maturities where the credit spread/default probability ratio is highest for Goldman Sachs Group. We also consider whether or not a reasonable investor would judge the firm to be "investment grade" under the June 2012 rules mandated by the Dodd-Frank Act of 2010.

10 Best Clean Energy Stocks To Watch For 2015: Somaxon Pharmaceuticals Inc.(SOMX)

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the in-licensing, development, and commercialization of proprietary branded products and late-stage product candidates for the treatment medical conditions in the central nervous system therapeutic area. Its product includes Silenor for the treatment of insomnia characterized by difficulty with sleep maintenance. The company sells its products to wholesale distributors in the United States. Somaxon Pharmaceuticals, Inc. was founded in 2003 and is headquartered in San Diego, California.

Advisors' Opinion:

• [By CRWE]

  Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company, will release its financial results for the third quarter ended September 30, 2012 on Wednesday, October 31, 2012 after the close of the U.S. financial markets.

10 Best Forestry Stocks To Invest In Right Now: Shoe Carnival Inc (SCVL)

Shoe Carnival, Inc. is a family footwear retailer. The Company offers customers an assortment of dress, casual and athletic footwear for men, women and children with emphasis on national and regional name brands. The Company�� stores averaged approximately 10,800 square feet, ranging in size from 6,000 to 26,500 square feet. As of January 28, 2012, the Company operated 327 stores located across 32 states and offered online shopping at www.shoecarnival.com. Its average store carries approximately 28,500 pairs of shoes in four general categories, such as men��, women��, children�� and athletics. In addition to footwear, its stores carry selected accessory items complementary to the sale of footwear.

The Company operates a single 410,000 square foot distribution center located in Evansville, Indiana. Women��, men�� and children�� non-athletic footwear categories are further divided into dress, casual, sport, sandals and boots. It classifies athletic shoes by functionality, such as running, basketball or fitness shoes. During the fiscal year ended January 28, 2012 (fiscal 2011), athletic styles, including children�� sizes, have represented approximately 50% of its footwear sales.

Advisors' Opinion:

• [By Maria Armental and Tess Stynes var popups = dojo.query(".socialByline .popC"); ]

  Shoe Carnival Inc.(SCVL) sales were hurt by harsh winter weather conditions and weak traffic, as the company reported a 4% earnings drop for the first quarter. The Indiana footwear and accessories chain’s results missed expectations, and the company issued a weaker projection for the current quarter.

• [By Jeremy Bowman]

  What: Shares of Shoe Carnival (NASDAQ: SCVL  ) were partying on Friday, gaining as much as 10% after reporting a strong first quarter.

  So what: The shoe-selling chain turned in a per-share profit of $0.47, $0.07 ahead of the analyst consensus, while revenue crept up 4.3% thanks to an 8% increase in store count over the year. Same-store sales, however, decreased 0.8%, perhaps indicating organic weakness in the retailer. CEO Cliff Sifford noted "the colder, wetter weather" made the quarter "challenging," as many other retailers have said this season. Better weather in April improved the sales trajectory and helped the company beat expectations. Its outlook for the current quarter was in line with estimates with an EPS of $0.26-$0.30 and same-stores increasing 3-5%.

• [By DailyFinance Staff]

  Job creation last month was shockingly weak, but analysts couldn't really explain why –- other than to blame the weather -- which left investors unsure how to react Friday. Many analysts say the numbers are likely to be revised higher next month, and in the end, market reaction was muted. The Dow Jones industrial average (^DJI) lost ground for a third straight day, declining nearly 8 points, but the Standard & Poor's 500 index (^GPSC) added 4, and the Nasdaq composite index (^IXIC) rose 18 points. Target (TGT) lost more than a point after saying the data breach that began on Black Friday was much worse than previously thought. The company now says as many as 70 million customers had personal information stolen. Target also lowered its fourth quarter outlook, partly because sales slumped after the data breach was first revealed. Sears (SHLD) tumbled by around 13.5 percent. It expects a big quarterly loss as sales fell during the holiday shopping season. Several smaller, specialty retailers also fell: Pacific Sunwear (PSUN) slid 16 percent, Five Below (FIVE) fell 7 percent, Shoe Carnival (SCVL) lost 5 percent, and Conn's (CONN) lost 2 percent. But Abercrombie & Fitch (ANF) jumped 12 percent. It raised its earnings forecast as sales were not as bad as expected. Elsewhere, Alcoa (AA) fell about 5.5 percent. It's not quite the economic bellwether it used to be, but the aluminum giant still matters, and its net came in a bit shy of expectations. YRC Worldwide (YRCW) tumbled 13 percent after workers rejected a contract offer. That has raised fears the trucking company could be forced into bankruptcy. On the upside, the weak jobs report could keep mortgage rates from rising, and that boosted housing stocks. KB Homes (KBH) rose 3 percent, William Lyons up 4 percent, and Lennar (LEN) was up 2 percent. And on Thursday we reported that shares of Intercept Pharmaceuticals nearly quadrupled in price on news of a positive clinical study for its liver dr

• [By Lauren Pollock]

  Shoe Carnival Inc.'s(SCVL) fiscal third-quarter earnings slid 11%, with revenue declining due to an unfavorable calendar shift from the previous year.

10 Best Forestry Stocks To Invest In Right Now: Medical Properties Trust Inc (MPW)

Medical Properties Trust, Inc., incorporated on August 27, 2003, is a self-advised real estate investment trust (REIT) focused on investing in and owning net-leased healthcare facilities. The Company conducts substantially all of its business through MPT Operating Partnership, L.P. The Company acquires and develops healthcare facilities and leases the facilities to healthcare operating companies under long-term net leases, which require the tenant to bear the costs associated with the property. The Company also makes mortgage loans to healthcare operators collateralized by their real estate assets. In addition, the Company selectively makes loans to certain of its operators through its taxable REIT subsidiaries. In September 2013, Medical Properties Trust Inc completed the acquisition of the real estate of three acute care hospitals operated by IASIS Healthcare LLC.

As of February 18, 2013, the Company's portfolio consists of 82 properties: 69 facilities (of the 74 facilities that the Company owns) are leased to 23 tenants, five are under development, and the remainder are in the form of mortgage loans to three operators. The Company's owned facilities consist of 27 general acute care hospitals, 24 long-term acute care hospitals, 15 inpatient rehabilitation hospitals, two medical office buildings, and six wellness centers. The non-owned facilities on which the Company has made mortgage loans consist of three general acute care facilities, two long-term acute care hospitals, and three inpatient rehabilitation hospitals. At December 31, 2012, no one property accounted for more than 5% of the Company's total assets.

At December 31, 2012, the Company had leases with 22 hospital operating companies, eight mortgaged loans, six under development, and one property under re-development covering 82 facilities. Ernest leased 12 of these facilities pursuant to a master lease agreement. The master lease agreement has a 20-year term with three five-year extension options and provides for ! an initial rental rate of 9%, with consumer price-indexed increases, limited to a 2% floor and 5% ceiling annually thereafter. At December 31, 2012, these facilities had an average remaining lease term of approximately 19 years. In addition to the master lease, the Company holds a mortgage loan on four facilities owned by affiliates of Ernest.

Affiliates of Prime Healthcare Services, Inc. (Prime) leased 11 facilities pursuant to master lease agreements. The master leases are for 10 years commencing July 3, 2012 and contain two renewal options of five years each. The initial lease rate is generally consistent with the blended average rate of the prior lease agreements. However, the annual escalators, which in the prior leases were limited, have been increased to reflect 100% of CPI increases, along with a 2% minimum floor. The master leases include repurchase options substantially similar to those in the prior leases, including provisions establishing minimum repurchase prices equal to the Company's total investment. In addition to leases, the Company holds mortgage loans on three facilities owned by affiliates of Prime.

Advisors' Opinion:

• [By Rich Duprey]

  Real estate investment trust�Medical Properties Trust� (NYSE: MPW  ) �announced yesterday�its second-quarter dividend of $0.20 per share, the same rate it's paid since 2008.

• [By Brad Thomas]

  A Bank of America (BOA) downgrade sends Medical Properties Trust (MPW) tumbling. The bank cut the shares to Underperform from Neutral citing the REIT's YTD outperformance relative to the sector overall (it has outpaced healthcare REITs two to one). Put simply, funds from operations "multiple expansion has exceeded fundamental trends." SA contributor Brad Thomas claims MPW is an example of mispriced risk.

10 Best Forestry Stocks To Invest In Right Now: Medivation Inc.(MDVN)

Medivation, Inc., a biopharmaceutical company, focuses on the development of small molecule drugs for the treatment of castration-resistant prostate cancer, Alzheimer?s disease, and Huntington disease. The company?s product candidates under clinical development include MDV3100, which is in Phase 3 development for the treatment of castration-resistant prostate cancer; and dimebon, which is in Phase 3 clinical trial for the treatment of Alzheimer?s disease and Huntington disease. It has collaboration agreements with Pfizer Inc. to develop and commercialize dimebon; and Astellas Pharma Inc. to develop and commercialize MDV3100. The company was founded in 2003 and is based in San Francisco, California.

Advisors' Opinion:

• [By Keith Speights]

  Medivation (NASDAQ: MDVN  ) also presents a threat to Provenge. The biotech obtained approval for Xtandi last August. The prostate cancer drug is approved for patients who weren't helped by chemotherapy.

• [By Ben Levisohn]

  While we lean positive on the large cap names across the board, including Neutral-rated names [Biogen (BIIB)] and [Celgene (CELG)], we single out [Gilead Sciences (GILD)] as our favourite into YE13e and into 2014. Among mid caps, we favor…[Medivation (MDVN).]

• [By Sean Williams]

  What: Shares of biopharmaceutical company Medivation (NASDAQ: MDVN  ) sank as much as 11% after rival Johnson & Johnson (NYSE: JNJ  ) announced it was purchasing Aragon Pharmaceuticals to get ahold of its experimental advanced prostate cancer drug, ARN-509.

• [By Lee Jackson]

  Medivation Inc. (NASDAQ: MDVN) is a top stock to buy and makes the UBS Key Call list as well. The company expects to present top line phase 3 data from the crucial PREVAIL trial of Xtandi in castration-resistant metastatic prostate cancer. UBS is highly confident the trials will prove successful. Its price target for the stock is $74, and the consensus target is $69.50.

10 Best Forestry Stocks To Invest In Right Now: ServiceSource International Inc.(SREV)

ServiceSource International, Inc. manages the service contract renewals process of maintenance, support and subscription agreements for technology and technology-enabled healthcare, and life sciences companies. The company provides end-to-end management and optimization of the service contract renewals process, including data management, quoting, selling, and service revenue business intelligence. It offers an integrated solution that consists of Service Revenue Intelligence Platform, a data warehouse of transactional, analytical, and industry data that provides insight into the business; service sales teams working under its customers? brands; and Service Revenue Performance Suite, a suite of cloud applications. The company?s cloud applications include Analytics Cloud, which provides customers with dashboards to view and analyze service revenue performance; Service Sales Cloud that provides renewals analytics and pipeline management used by service sales teams; and Chan nel Sales Cloud, which offers channel partners and resellers with online access to their specific renewals opportunities and their performance. Its cloud applications also comprise eCommerce Cloud that provides self-service capabilities to end customers through a secure online portal; Installed Base Intelligence Cloud, which offers a single repository to analyze the data, to flag anomalies and missing data elements, and to identify cross-sell and up-sell opportunities; and Dynamic Quoting Cloud that provides an easy-to-use tool for sales representatives and channel partners to create and modify service renewal quotes. The company sells its solutions directly through sales representatives in North America, Latin America, Europe, the Middle East, Africa, the Asia Pacific, and Japan. ServiceSource International, Inc. was founded in 2002 and is headquartered in San Francisco, California with additional offices in Colorado, Tennessee, Ireland, the United Kingdom, Malaysia, and Si ngapore.

Advisors' Opinion:

• [By Evan Niu, CFA]

  What: Shares of ServiceSource (NASDAQ: SREV  ) have soared by as much as 24% today after the company reported first-quarter earnings.

  So what: Revenue in the first quarter totaled $61.1 million, higher than the $60.4 million consensus estimate. The non-GAAP net loss of $1.5 million, or $0.02 per share, was also better than the $0.04-per-share loss that investors were expecting. The company inked four new Renew OnDemand subscription deals during the quarter.

• [By Steve Symington]

  What:�Shares of Servicesource International Inc (NASDAQ: SREV  ) plunged nearly 33% Friday after the recurring-revenue-management company turned in disappointing first-quarter results.

• [By Lee Jackson]

  Service Source International Inc. (NASDAQ: SREV) is a small cap name with big possibilities. The company provides recurring revenue management contracts maintenance, support and subscription for technology and technology-enabled health care and life sciences companies. The consensus price objective for the stock is $14.

• [By Jake L'Ecuyer]

  ServiceSource (NASDAQ: SREV) shares were also down, falling 32.48 percent to $4.22 as the company missed on earnings and caught a downgrade from CLSA from Buy to Underperform.

10 Best Forestry Stocks To Invest In Right Now: Techne Corporation(TECH)

TECHNE Corporation develops, manufactures, and sells biotechnology products, and hematology calibrators and controls worldwide. The company?s Biotechnology segment offers proteins, such as cytokines, and enzyme substrates and inhibitors; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits for the detection of human and animal proteins, and immunoassays that allow researchers to quantify a specific analyte in a biological fluids sample; clinical diagnostic immunoassay kits consisting of erythropoietin, transferrin receptor, and beta2-microglobulin immunoassays for use as in vitro diagnostic devices; flow cytometry products, such as fluorochrome labeled antibodies and kits; intracellular cell signaling products, including antibodies, phospho-specific antibodies, antibody arrays, active caspases, kinases, and phosphatases, and ELISA assays to measure the activity of apoptotic and signaling molecules; and natural and synthetic c hemical compounds for use as agonists, antagonists, and inhibitors of various biological functions by investigators. Its Hematology segment provides whole blood CBC controls controls and calibrators; linearity and reportable range controls for the assessment of the linearity of hematology analyzers for white blood cells, red blood cells, platelets, and reticulocytes; whole blood reticulocyte controls for manual and automated counting of reticulocytes; whole blood flow cytometry controls for the identification and quantification white blood cells; whole blood glucose/hemoglobin control to monitor instruments, which measure glucose and hemoglobin in blood; erythrocyte sedimentation rate control to monitor erythrocyte sedimentation rate tests; and multi-purpose platelet reference controls, such as Platelet-Trol II and Platelet-Trol Extended for use by automated and semi-automated analyzers, which monitor platelet levels. The company was founded in 1976 and is headquartered in M inneapolis, Minnesota.

Advisors' Opinion:

• [By Rich Duprey]

  Medical device maker Techne (NASDAQ: TECH  ) announced today that it's taking a 100% ownership stake in�Bionostics Holdings for $104 million cash.

• [By Rich Duprey]

  Biologics researcher�Techne� (NASDAQ: TECH  ) �will pay a regular quarterly dividend of $0.30 on May 24 to the holders of record at the close of business on May 10.

10 Best Forestry Stocks To Invest In Right Now: EMCORE Corporation(EMKR)

EMCORE Corporation, together with its subsidiaries, provides compound semiconductor-based products for the broadband, fiber optics, satellite, and solar power markets. The company operates in two segments, Fiber Optics and Photovoltaics. The Fiber Optics segment offers broadband products, including cable television, fiber-to-the-premises, satellite communication, video transport, and defense and homeland security products; and digital products comprising telecom optical, enterprise, laser/photodetector component, parallel optical transceiver and cable, and fiber channel transceiver products. This segment?s products enable information that is encoded on light signals to be transmitted, routed, and received in communication systems and networks. The Photovoltaics segment provides gallium arsenide (GaAs) multi-junction solar cells, covered interconnected cells, and solar panels for satellite applications; and concentrating photovoltaic (CPV) power systems for commercial and utility scale solar applications, as well as GaAs solar cells and integrated CPV components for use in other solar power concentrator systems. The company markets its products through its direct sales force, external sales representatives and distributors, and application engineers worldwide. EMCORE Corporation was founded in 1984 and is headquartered in Albuquerque, New Mexico.

Advisors' Opinion:

• [By CRWE]

  EMCORE Corporation (Nasdaq:EMKR), a leading provider of compound semiconductor-based components and subsystems for the fiber optic and solar power markets, reported that it is ramping production and shipping the Opticomm-EMCORE NEXTGEN OTP-1DVI2A1SU insert cards for the Optiva platform.